Rarity Bioscience Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $20M

  • Investors
  • 5

Rarity Bioscience General Information

Description

Developer of molecular amplification technology designed to detect small amounts of DNA sequence variants. The company's platform uses an ultrasensitive multiplex assay for detecting rare nucleic acid sequences in biological samples like liquid biopsies, enabling physicians with technology for research as well as clinical applications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Dag Hammarskjölds Väg 56E
  • 752 37 Uppsala
  • Sweden
+46
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Dag Hammarskjölds Väg 56E
  • 752 37 Uppsala
  • Sweden
+46

Rarity Bioscience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rarity Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC $20M Upcoming Product Development
4. Early Stage VC 18-Jun-2024 Completed Product Development
3. Seed Round 01-Dec-2022 Completed Product Development
2. Angel (individual) 12-Jul-2021 $1.76M $1.76M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Rarity Bioscience’s complete valuation and funding history, request access »

Rarity Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 15,000 $94.71 $94.71 1x $94.71 20.4%
To view Rarity Bioscience’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rarity Bioscience Patents

Rarity Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202506768-D0 Detection of srca products by flow cytometry Pending 02-May-2025
WO-2026229595-A1 Detection of srca products by flow cytometry Pending 02-May-2025
EP-4677110-A1 Improved method for detecting a target variant base using a variant-specific probe Pending 08-Mar-2023
GB-202303359-D0 Improved method for detecting a target variant base using a variant-specific probe Inactive 08-Mar-2023
US-20260242853-A1 Improved method for detecting a target variant base using a variant-specific probe Pending 08-Mar-2023 C12Q1/6827
To view Rarity Bioscience’s complete patent history, request access »

Rarity Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rarity Bioscience Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Navigare Ventures Venture Capital Minority
Novalis Biotech Venture Capital Minority
UU Invest Venture Capital Minority
STUNS Life Science Accelerator/Incubator Minority
To view Rarity Bioscience’s complete investors history, request access »

Rarity Bioscience FAQs

  • When was Rarity Bioscience founded?

    Rarity Bioscience was founded in 2021.

  • Where is Rarity Bioscience headquartered?

    Rarity Bioscience is headquartered in Uppsala, Sweden.

  • What is the size of Rarity Bioscience?

    Rarity Bioscience has 30 total employees.

  • What industry is Rarity Bioscience in?

    Rarity Bioscience’s primary industry is Other Devices and Supplies.

  • Is Rarity Bioscience a private or public company?

    Rarity Bioscience is a Private company.

  • What is Rarity Bioscience’s current revenue?

    The current revenue for Rarity Bioscience is .

  • How much funding has Rarity Bioscience raised over time?

    Rarity Bioscience has raised $11.7M.

  • Who are Rarity Bioscience’s investors?

    , Navigare Ventures, Novalis Biotech, UU Invest, and STUNS Life Science have invested in Rarity Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process